This is a Validated Antibody Database (VAD) review about human CD32, based on 39 published articles (read how Labome selects the articles), using CD32 antibody in all methods. It is aimed to help Labome visitors find the most suited CD32 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD32 synonym: CD32; CD32A; CDw32; FCG2; FCGR2; FCGR2A1; FcGR; IGFR2

BioLegend
mouse monoclonal (FUN-2)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD32 antibody (BioLegend, FUN-2) was used in flow cytometry on human samples (fig 1b). Arthritis Res Ther (2020) ncbi
mouse monoclonal (FUN-2)
  • mass cytometry; human; loading ...; fig 1b, 1d, s2
BioLegend CD32 antibody (Biolegend, FUN-2) was used in mass cytometry on human samples (fig 1b, 1d, s2). Cell Rep (2019) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; loading ...; fig 7a, 7c, 7e
BioLegend CD32 antibody (BioLegend, FUN-2) was used in flow cytometry on human samples (fig 7a, 7c, 7e). J Clin Invest (2019) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; loading ...; fig s1c
BioLegend CD32 antibody (Biolegend, FUN-2) was used in flow cytometry on human samples (fig s1c). Front Immunol (2019) ncbi
mouse monoclonal (FUN-2)
  • mass cytometry; human; loading ...; fig 2j
BioLegend CD32 antibody (Biolegend, 303202) was used in mass cytometry on human samples (fig 2j). Cell (2019) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD32 antibody (BioLegend, FUN-2) was used in flow cytometry on human samples (fig 1a). J Virol (2018) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; 1:100
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., BioLegend CD32 antibody (BioLegend, FUN-2) was used in flow cytometry on human samples at 1:100. Nature (2017) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; fig 5
In order to show that IL-3 is a potent inducer of CD32- and alphaMbeta2-mediated eosinophil degranulation, BioLegend CD32 antibody (Biolegend, FUN-2) was used in flow cytometry on human samples (fig 5). Clin Exp Allergy (2017) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BioLegend CD32 antibody (BioLegend, FUN-2) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CD32 antibody (BioLegend, FUN-2) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (FUN-2)
  • flow cytometry; human; fig 2
BioLegend CD32 antibody (BioLegend, FUN-2) was used in flow cytometry on human samples (fig 2). Int Immunol (2015) ncbi
Invitrogen
mouse monoclonal (6C4 (CD32))
  • flow cytometry; human; loading ...; fig 3c
Invitrogen CD32 antibody (eBioscience, 6C4) was used in flow cytometry on human samples (fig 3c). Antioxidants (Basel) (2020) ncbi
mouse monoclonal (6C4 (CD32))
  • flow cytometry; human; fig s1g
Invitrogen CD32 antibody (eBiosciences, 11-0329-42) was used in flow cytometry on human samples (fig s1g). Cell Rep (2019) ncbi
mouse monoclonal (6C4 (CD32))
  • mass cytometry; human; loading ...; fig s4b
Invitrogen CD32 antibody (eBioscience, 6C4) was used in mass cytometry on human samples (fig s4b). Science (2019) ncbi
mouse monoclonal (6C4 (CD32))
  • flow cytometry; human; loading ...; fig s1b
Invitrogen CD32 antibody (eBioscience, 6C4) was used in flow cytometry on human samples (fig s1b). Cell Host Microbe (2019) ncbi
mouse monoclonal (6C4 (CD32))
  • flow cytometry; human; loading ...; fig 1a
In order to elucidate the role of pattern recognition receptors in Bechet's disease, Invitrogen CD32 antibody (eBioscience, 17-0329-42) was used in flow cytometry on human samples (fig 1a). Mediators Inflamm (2017) ncbi
mouse monoclonal (6C4 (CD32))
  • flow cytometry; human; fig 6a
In order to generate cell line to examine the molecular events controlling HIV expression in the microglia, Invitrogen CD32 antibody (eBioscience, 17-0329) was used in flow cytometry on human samples (fig 6a). J Neurovirol (2017) ncbi
mouse monoclonal (AT10)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Invitrogen CD32 antibody (Invitrogen, AT10) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
Bio-Rad
mouse monoclonal (AT10)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 5a
Bio-Rad CD32 antibody (Bio-Rad, MCA1075) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5a). J Neuroinflammation (2020) ncbi
mouse monoclonal (AT10)
  • flow cytometry; human; loading ...; fig 5b
Bio-Rad CD32 antibody (AbD Serotec, AT 10) was used in flow cytometry on human samples (fig 5b). Front Immunol (2018) ncbi
mouse monoclonal (AT10)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, Bio-Rad CD32 antibody (AbD Serotec, MCA1075PE) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi
mouse monoclonal (AT10)
  • flow cytometry; human; loading ...; fig 1a
Bio-Rad CD32 antibody (AbD Serotec, AT10) was used in flow cytometry on human samples (fig 1a). Haematologica (2016) ncbi
mouse monoclonal (AT10)
  • flow cytometry; hamsters
Bio-Rad CD32 antibody (AbD Serotec, AT10) was used in flow cytometry on hamsters samples . PLoS ONE (2014) ncbi
mouse monoclonal (AT10)
  • immunohistochemistry - frozen section; human; 1:2000
  • flow cytometry; human; 1:500
Bio-Rad CD32 antibody (Serotec, MCA1075) was used in immunohistochemistry - frozen section on human samples at 1:2000 and in flow cytometry on human samples at 1:500. J Neuroinflammation (2013) ncbi
Stemcell Technologies
monoclonal
  • flow cytometry; human; fig 2
In order to describe an Fc engineering approach that specifically affects antibody-dependent cytokine release, Stemcell Technologies CD32 antibody (StemCell Technologies, 01470) was used in flow cytometry on human samples (fig 2). MAbs (2015) ncbi
BD Biosciences
mouse monoclonal (FLI8.26)
  • flow cytometry; human; loading ...; fig 5
BD Biosciences CD32 antibody (BD Pharmingen, FLI8.26) was used in flow cytometry on human samples (fig 5). Respir Res (2017) ncbi
mouse monoclonal (3D3)
  • blocking or activating experiments; human; loading ...
BD Biosciences CD32 antibody (BD Biosciences, 551900) was used in blocking or activating experiments on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (3D3)
  • flow cytometry; human; 1:100; loading ...; fig 2e
In order to discuss cell type accountable for parvovirus B19 DNA tissue persistence, BD Biosciences CD32 antibody (BD Biosciences, 551900) was used in flow cytometry on human samples at 1:100 (fig 2e). Nat Commun (2017) ncbi
mouse monoclonal (FLI8.26)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD32 antibody (BD Biosciences, FL18-26) was used in flow cytometry on human samples (fig s2). Nature (2017) ncbi
mouse monoclonal (FLI8.26)
  • flow cytometry; human; loading ...; fig s1d
  • immunocytochemistry; human
In order to determine the localization of FcgammaRI, FcgammaRII, and SIRPalpha in macrophages, BD Biosciences CD32 antibody (BD, FLI8.26) was used in flow cytometry on human samples (fig s1d) and in immunocytochemistry on human samples . J Cell Biol (2017) ncbi
mouse monoclonal (FLI8.26)
  • flow cytometry; human; loading ...; fig 1f
BD Biosciences CD32 antibody (BD Biosciences, 559769) was used in flow cytometry on human samples (fig 1f). Oncoimmunology (2016) ncbi
mouse monoclonal (FLI8.26)
  • flow cytometry; human; loading ...; fig 2a
In order to screen to find antibodies that block HIV-1 acquisition and replication, BD Biosciences CD32 antibody (BD Biosciences, FLI8.26) was used in flow cytometry on human samples (fig 2a). J Virol (2017) ncbi
mouse monoclonal (FLI8.26)
  • blocking or activating experiments; human; fig 1
BD Biosciences CD32 antibody (BD Biosciences, 555447) was used in blocking or activating experiments on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (3D3)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD32 antibody (BD, 552884) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (3D3)
  • flow cytometry; human
In order to test if macrophages contribute to the effect of daratumumab treatment, BD Biosciences CD32 antibody (BD, 552883) was used in flow cytometry on human samples . MAbs (2015) ncbi
mouse monoclonal (FLI8.26)
  • flow cytometry; human; fig 4
BD Biosciences CD32 antibody (BD Biosciences, FLI8.26) was used in flow cytometry on human samples (fig 4). J Infect Dis (2015) ncbi
mouse monoclonal (FLI8.26)
  • flow cytometry; human
BD Biosciences CD32 antibody (BD Biosciences, FLI8.26) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (FLI8.26)
  • flow cytometry; human
BD Biosciences CD32 antibody (BD Biosciences, FLI8-26) was used in flow cytometry on human samples . J Allergy Clin Immunol (2014) ncbi
ATCC
mouse monoclonal
  • immunocytochemistry; human; loading ...; fig 1g
  • western blot; human; loading ...; fig 6b
In order to demonstrate that cross-linking FcgammaRIIIb is responsible for neutrophil extracellular trap formation by the human neutrophil, ATCC CD32 antibody (ATCC, HB-217) was used in immunocytochemistry on human samples (fig 1g) and in western blot on human samples (fig 6b). J Immunol Res (2016) ncbi
Articles Reviewed
  1. Pu A, Mishra M, Dong Y, Ghorbanigazar S, Stephenson E, Rawji K, et al. The glycosyltransferase EXTL2 promotes proteoglycan deposition and injurious neuroinflammation following demyelination. J Neuroinflammation. 2020;17:220 pubmed publisher
  2. Bengtsson A, Tydén H, Lood C. Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus. Arthritis Res Ther. 2020;22:126 pubmed publisher
  3. Bekeschus S, Ressel V, Freund E, Gelbrich N, Mustea A, Stope M. Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity. Antioxidants (Basel). 2020;9: pubmed publisher
  4. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  5. Vijayaraj P, Minasyan A, Durra A, Karumbayaram S, Mehrabi M, Aros C, et al. Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule. Cell Rep. 2019;29:3488-3505.e9 pubmed publisher
  6. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  7. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  8. Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S, et al. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 2019;10:951 pubmed publisher
  9. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  10. Bottermann M, Foss S, Caddy S, Clift D, van Tienen L, Vaysburd M, et al. Complement C4 Prevents Viral Infection through Capsid Inactivation. Cell Host Microbe. 2019;25:617-629.e7 pubmed publisher
  11. Noto A, Procopio F, Banga R, Suffiotti M, Corpataux J, Cavassini M, et al. CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals. J Virol. 2018;92: pubmed publisher
  12. Jimenez R, Wright T, Jones N, Wu J, Gibson A, Szalai A. C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. Front Immunol. 2018;9:372 pubmed publisher
  13. Loi A, Hoonhorst S, van Aalst C, Langereis J, Kamp V, Sluis Eising S, et al. Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients. Respir Res. 2017;18:100 pubmed publisher
  14. Choi B, Suh C, Kim H, Sayeed H, Sohn S. The Correlation of CD206, CD209, and Disease Severity in Behçet's Disease with Arthritis. Mediators Inflamm. 2017;2017:7539529 pubmed publisher
  15. Kim S, Kim S, Bae D, Park S, Lee G, Park G, et al. Coordinated balance of Rac1 and RhoA plays key roles in determining phagocytic appetite. PLoS ONE. 2017;12:e0174603 pubmed publisher
  16. Pyöriä L, Toppinen M, Mäntylä E, Hedman L, Aaltonen L, Vihinen Ranta M, et al. Extinct type of human parvovirus B19 persists in tonsillar B cells. Nat Commun. 2017;8:14930 pubmed publisher
  17. Descours B, Petitjean G, López Zaragoza J, Bruel T, Raffel R, Psomas C, et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;543:564-567 pubmed publisher
  18. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed publisher
  19. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  20. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  21. Esnault S, Johansson M, Kelly E, Koenderman L, Mosher D, Jarjour N. IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation. Clin Exp Allergy. 2017;47:488-498 pubmed publisher
  22. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  23. Garcia Mesa Y, Jay T, Checkley M, Luttge B, Dobrowolski C, Valadkhan S, et al. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system. J Neurovirol. 2017;23:47-66 pubmed publisher
  24. Cheeseman H, Olejniczak N, Rogers P, Evans A, King D, Ziprin P, et al. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. J Virol. 2017;91: pubmed publisher
  25. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  26. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  27. Alemán O, Mora N, Cortés Vieyra R, Uribe Querol E, Rosales C. Differential Use of Human Neutrophil Fc? Receptors for Inducing Neutrophil Extracellular Trap Formation. J Immunol Res. 2016;2016:2908034 pubmed publisher
  28. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
  29. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  30. Gazendam R, van de Geer A, van Hamme J, Tool A, van Rees D, Aarts C, et al. Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components. Haematologica. 2016;101:587-96 pubmed publisher
  31. Kinder M, Greenplate A, Strohl W, Jordan R, Brezski R. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. MAbs. 2015;7:494-504 pubmed publisher
  32. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  33. Overdijk M, Verploegen S, Bögels M, van Egmond M, Lammerts van Bueren J, Mutis T, et al. Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. MAbs. 2015;7:311-21 pubmed publisher
  34. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed publisher
  35. Armour K, Smith C, Ip N, Ellison C, Kirton C, Wilkes A, et al. Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines. PLoS ONE. 2014;9:e109463 pubmed publisher
  36. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed publisher
  37. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  38. Lighaam L, Vermeulen E, Bleker T, Meijlink K, Aalberse R, Barnes E, et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2014;133:267-70.e1-6 pubmed publisher
  39. Vogel D, Vereyken E, Glim J, Heijnen P, Moeton M, van der Valk P, et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation. 2013;10:35 pubmed publisher